Table 3.
—Hospital resource use (excluding visits for OMALIZUMAB administration).
| Mean (SD) | Mean (SD) | |||
|---|---|---|---|---|
| Resource | pre-OMALIZUMAB | post-OMALIZUMAB | Difference | Paired t-test |
| A&E visits | 1.52 (2.194) | 0.46 (1.419) | −1.07 (2.383) | p < .001 |
| Inpatient hospitalizations | 1.30 (1.731) | 0.51 (1.102) | −0.79 (1.830) | p < .001 |
| Bed days (all subjects) | 9.10 (14.438) | 2.97 (6.343) | −6.13 (14.243) | p < .001 |
| Inpatient hospitalizations (hospitalized subset a , n = 81) | 2.19 (1.761) | 0.65 (1.247) | −1.53 (1.963) | p < .001 |
| Bed days (hospitalized subset, n = 81) | 14.86 (16.341) | 3.83 (6.939) | −11.04 (16.176) | p < .001 |
| Respiratory outpatient visits | 6.00 (3.432) | 5.71 (4.360) | −0.29 (4.968) | p = .49 |
| Telephone consultations | 0.23 (0.877) | 0.11 (0.416) | −0.12 (0.656) | p= .0384 |
| Nurse consultations | 1.24 (2.209) | 1.69 (3.954) | 0.46 (3.559) | p = .1375 |
| Doctor consultations | 4.54 (3.277) | 3.82 (3.250) | −0.71 (3.434) | p = .0168 |
| MDT consultations | 0.06 (0.266) | 0.00 (0.000) | −0.06 (0.266) | p = .0109 |
| Pharmacist consultations | 0.05 (0.372) | 0.06 (0.360) | 0.01 (0.333) | p = .7973 |
Note: aPatients hospitalized in the 12 months pre-OMALIZUMAB initiation.